By Advocates of the medical use of psilocybin mushrooms in Canada have launched a petition urging the federal government to take action. Interest in psilocybin-supported therapy continues to grow to combat end-of-life anxiety, depression, AD, and PTSD, among many other conditions.
Petition e-4334 An online “Petition to the Government of Canada” was launched on March 16. This must be submitted to the House of Commons if the conditions are met, according to law. specific conditions, microdosing reportPetitions, for example, must be certified by a petition clerk in order to be submitted to the House of Commons. It also requires the signatures of at least her 500 residents of Canada and approval by members of parliament.
Proponents want all forms of therapeutic psilocybin to be greenlit, citing a few specific conditions that could improve.
“We, the undersigned, compassionate Canadians, call upon the Government of Canada to grant unrestricted access to therapeutic psilocybin as and when required by Canadians through Section 56 exemptions. I ask,” the petition reads.
The petition offers three reasons why psilocybin-supported therapy should be legalized, including the mushroom’s low potential for harm.
- There is strong medical evidence that access to psychedelic supportive therapy can effectively treat existential distress and improve quality of life in death, depression, anxiety, addiction, PTSD, and other mental health conditions. exists.
- Psilocybin, which is required for psilocybin-supported therapy, is currently only available in clinical trials and requires special individual authorization from Health Canada, despite the low potential for harm.and
- It is paradoxical and unethical to allow a doctor to provide MAID to a patient while preventing the same doctor from treating terminal affliction with psilocybin.
To sign the petition, the signer must be a Canadian citizen or resident of Canada.
Psilocybin-supported therapy in Canada
Meanwhile, there is a case in which the issue of psilocybin-supported therapy has attracted attention.
Saskatoon-based Thomas Hartle First person in Canada to receive a legal psychedelic assisted therapy session to treat his terminal anxiety. However, a year later, his authorization from Health Canada expired in October 2021, he had to reapply.
Thomas waited over 500 days for approval, but his exemption to continue using psilocybin for medical purposes was denied by Minister Carolyn Bennett. Health Canada has denied Hartle permission to continue psilocybin-supported therapy, which has drawn much attention and criticism from the psychedelic community. Hartle believes that Health Canada and the Minister of Health are just waiting for his death.
Psychotherapy with psilocybin is the only method that has helped him deal with terminal anxiety, he says, requiring safe and legal access.
It’s stories like Hartle’s that are driving efforts to legalize adjuvant psilocybin therapy in Canada.
Research into the potential benefits of psilocybin continues to unfold. First North American take-home study of psilocybin approved in Canada.a pharmaceutical company called Apex Lab On November 1, 2022, First multi-dose psilocybin clinical trial in North AmericaApex Labs is a patient-driven pharmaceutical company specializing in psilocybin treatment for veterans.
Apex Labs will initiate a trial investigating the efficacy of APEX-52 (psilocybin) for veterans suffering from depression and post-traumatic stress disorder. Apex Labs received a “Letter of No Objection” from Health Canada on October 24, 2022.
A pharmacy offering psilocybin has popped up in Canada.Two men arrested, mushrooms later confiscated Raid on West Toronto Psilocybin Mushroom Pharmacy November last year.
The movement to legalize psilocybin-assisted therapy in Canada and explore its benefits continues its march.
